Irreversible Electrophysiological Deficits in Tamoxifen Optic Neuropathy After Clinical Resolution

Update Item Information
Identifier 20090224_nanos_posters_054.pdf
Title Irreversible Electrophysiological Deficits in Tamoxifen Optic Neuropathy After Clinical Resolution
Creator E-Shawn Goh; Su Ann Lim; Adrian Koh; Audrey Chia
Affiliation (EG) (SAL) Tan Tock Seng Hospital, Singapore, Singapore; (AK) Retina Associates, Singapore, Singapore; (AC) Singapore National Eye Centre, Singapore, Singapore
Subject Tamoxifen; Optic Neuropathy; Electrophysiology
Description Tamoxifen is an anti-estrogen drug used in the treatment of patients with breast cancer. Ocular toxicity is seen in the form of intra-retinal refractile crystals associated with macular edema, and occasionally from optic neuropathy. Optic neuropathy is largely reversible and rare cases of permanent visual impairment have been reported.
Date 2009-02-24
Language eng
Format application/pdf
Type Text
Source 2009 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2009: Poster Presentations
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6739x7f
Setname ehsl_novel_nam
ID 180600
Reference URL https://collections.lib.utah.edu/ark:/87278/s6739x7f
Back to Search Results